Skip to main content
Clinical Trials/NCT01055977
NCT01055977CompletedNot Applicable

Statin Therapy Results in the Real World Practice in the Czech Republic

AstraZeneca1 site in 1 country3,253 target enrollmentStarted: February 2010Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
3,253
Locations
1
Primary Endpoint
LDL-C

Study Overview

Brief Summary

Statins are the first choice treatment of dyslipidemia, a major contributor to cardiovascular diseases. Statins also have enough evidence to demonstrate decrease of morbidity and mortality from cardiovascular diseases. Even though statin therapy is effective treatment of dyslipidaemia not all patients reach the goal levels.

The aim of the study is to estimate proportion of patients who achieved the therapeutic goal (LDL-C. total cholesterol, HDL-C and triglycerides levels) after at least one year of a statin therapy.

Study Design

Study Type
Observational
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Documented statin therapy for at least 12 months
  • Available two LDL-C values: one at the beginning of statin therapy or at the time when patient comes to a specialist; and the other one at least after 12 months of treatment. The latter value should not be older than 6 months.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

LDL-C

Time Frame: one year

Secondary Outcomes

  • Total cholesterol(one year)
  • HDL-C(one year)
  • triglycerides(one year)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials